BOTHELL, Wash. —BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a multi-year supply agreement with Qkine Limited under which BioLife will distribute certain ctokine and growth factor products manufactured by Qkine for use in cell and gene […]
— Open Aperture provides no-cost access to TfR1 CapX, a leading central nervous system-targeting AAV capsid — NEW YORK, NY – Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today announced the launch of Open Aperture, a material transfer agreement program that provides qualified academic researchers with access to […]
The automation-compatible, bead-based method optimizes cfDNA recovery from plasma, serum, urine and cerebrospinal fluid IPSWICH, Mass. — New England Biolabs (NEB®) announces the release of the Monarch Mag Cell-free DNA (cfDNA) Extraction Kit, which enables consistent, scalable extraction of low-abundance, circulating cell-free DNA (cfDNA) for downstream applications including biomarker discovery and diagnostics development. The magnetic, bead-based workflow is […]
BOTHELL, Wash. — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a multi-year supply agreement with Qkine Limited under which BioLife will distribute certain ctokine and growth factor products manufactured by Qkine for use in cell and […]
Integration of HiFi Long-Read Whole-Genome Sequencing Expands the Collective Capabilities of iHope’s Global Rare Disease Network MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced a collaboration with iHope, a global rare disease genomics program of Genetic Alliance, to integrate PacBio’s HiFi® long-read whole-genome sequencing into iHope’s […]
Appointments to bolster rapid scaling and execution of Pyxa™ spatial platform BOSTON — Stellaromics, a pioneer in high-resolution 3D spatial multi-omics, today announced the appointment of Stacie Weninger, PhD, and Steve McPhail to its Board of Directors. These strategic appointments come at a pivotal time for the company as it scales its innovative Pyxa™ technology and […]
Dr. Matt McManus to transition from his role as President, Diagnostics and Spatial Biology Segment, effective March 1, 2026 Steve Crouse, Senior Vice President of Bio-Techne’s Analytical Solutions Division, has been appointed President, Diagnostics and Spatial Biology Segment, effective March 1, 2026 MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced that Dr. Matt McManus, President […]
Schlieren, Switzerland — InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed a partnership with PharmaNest Inc, a Princeton, NJ-based digital pathology company. This partnership uniquely positions InSphero’s in the space of the translational application of machine learning tools in combination with human pre-clinical models to decipher complex pathological phenotypes for the identification of effective therapies. A key challenge of these current unmet clinical needs is the prediction of the drug efficacy of complex fibrotic phenotypes in clinical stages. The […]
Advancing global operations and realigning domestic sites to strengthen the organization and lay the groundwork to become a company with annual revenue of 1 trillion yen. HORIBA, Ltd. (President: Masayuki Adachi) announces plans to build a new global headquarters on the site of its current head office in Kisshoin, Minami-ku, Kyoto. Construction began in December […]
FREMONT, Calif. — Ultima Genomics, a developer of an innovative, ultra-high throughput sequencing architecture, today announced the appointment of Elena Helman, PhD, as Vice President of Oncology Solutions. In this role, Elena will lead Ultima’s oncology solutions strategy, bringing deep expertise in cancer genomics, clinical diagnostics, and translational bioinformatics to support the company’s expansion into clinical […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
